Peter Welch bought Regeneron Pharmaceuticals Inc (NASDAQ: REGN)
Peter Welch (D-VT), a U.S. Senator, has disclosed 3 trades in Regeneron Pharmaceuticals Inc (REGN) since 2017, 2 purchases and 1 sale, worth an estimated $24K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Peter Welch bought $1,001 - $15,000 of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) on November 6, 2017. Since that trade, REGN is up +72.43% against the S&P 500 up +221.82%, an outperformance of -149.39%.
Across these filings, Peter Welch has been a net buyer of REGN (a buy-to-sell ratio of 2.00). The most recent disclosed REGN transaction shown was dated November 20, 2017. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Peter Welch's REGN trades vs the price
REGN is up +72.43% since Peter Welch bought on November 6, 2017, versus +221.82% for the S&P 500.
Performance since this trade
All Peter Welch REGN trades
Peter Welch & REGN trading FAQ
Is it legal for Peter Welch to trade Regeneron Pharmaceuticals Inc (REGN) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Regeneron Pharmaceuticals Inc (REGN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Peter Welch buy REGN?
Peter Welch disclosed a purchase of $1,001 - $15,000 of Regeneron Pharmaceuticals Inc (REGN) on November 6, 2017, according to public STOCK Act filings.
How has REGN performed since Peter Welch's trade?
Since Peter Welch bought REGN on November 6, 2017, the stock is up +72.43%, versus +221.82% for the S&P 500 over the same period, an outperformance of -149.39%.
How many times has Peter Welch traded REGN?
Peter Welch has disclosed 3 REGN trades since 2017 (2 purchases and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional REGN trades?
Quantellect tracks every disclosed congressional trade in Regeneron Pharmaceuticals Inc (REGN) on the Regeneron Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
Peter Welch's REGN tradesAll congressional filings for Regeneron Pharmaceuticals IncPeter Welch's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.